New York City detects first known case of severe Mpox strain, health department issues advisory – all you need to know
Mpox is an infectious disease that can cause symptoms such as a painful rash, swollen lymph nodes, fever, headache, muscle aches, back pain and fatigue. The first known case of a more severe strain of Mpox, known as Mpox clade I, was detected in New York City on Saturday
The first known case of a more severe strain of Mpox, known as Mpox clade I, was detected in New York City on Saturday, reported Fox 5. Since November 2024, 11 cases of the strain have been reported across the United States, according to health authorities.
On Friday, 13 March, the New York City Health Department issued a health advisory to health care providers after confirming the case.
Mpox clade I detected - What we know so far
The person who tested positive recently traveled internationally, reported Fox 5 – citing the NYC Health Department. Health officials said no other cases of the Mpox clade I strain have been detected in New York City, and that there is currently no evidence that the virus is spreading locally.
"There is no known local transmission of mpox clade I in New York City and the risk remains low for New Yorkers," the media outlet quoted NYC Health Commissioner Dr. Alister Martin as saying.
What is Mpox?
Mpox is an infectious disease that can cause symptoms such as a painful rash, swollen lymph nodes, fever, headache, muscle aches, back pain and fatigue. While most people recover fully, some cases can become severe, as per a WHO fact sheet.
Mpox is caused by the monkeypox virus (MPXV). It is an enveloped double-stranded DNA virus of the Orthopoxvirus genus in the Poxviridae family, which includes variola, cowpox, vaccinia and other viruses. There are two distinct clades of the virus: clade I (with subclades Ia and Ib) and clade II (with subclades IIa and IIb).
Is vaccination available for Mpox?
Health officials say that vaccination can lower the risk of contracting Mpox and help reduce the severity of symptoms.
People considered at risk are advised to receive the two-dose JYNNEOS vaccine series if they have not already been vaccinated. The second dose should be taken at least 28 days after the first.
For those who have previously had Mpox do not need to be vaccinated, as per health authorities.
About the Author
For about a decade, Livemint—News Desk has been a credible source for authentic and timely news, and well-researched analysis on national news, business, personal finance, corporates, politics and geopolitics. We bring the latest updates on all the listed companies on BSE and NSE, startups, mutual funds, Union ministries, geopolitics, and untapped human interest stories from around the world, helping our readers to stay informed on the latest developments around the globe. Our Coverage Areas 1. Companies: Comprehensive news and analysis on listed and unlisted companies, corporate announcements, corporate chatter, C-suite, business trends, hiring alerts, layoffs, work-life balance, world's top billionaires and richest and more. 2. Personal finance: Insights into mutual funds, small savings schemes like - PPF, SSY, post office savings scheme, stock to watch, personal loans, credit cards, top bank FDs, real estate, income tax and more. 3. Politics: Comprehensive coverage of general elections, state elections and bypolls, Lok Sabha, Vidhan Sabha, Parliament, PMO, PIB, finance ministry, home ministry, among other union ministries and government departments. 4. National News: From metro cities like Delhi, Mumbai, and e to untapped stories from rural India, we cover human interest, health, education, crime and courts, and law and order, among other areas of public interest. 5. Economy: In-depth analysis of India's macro and micro-economic indicators like- GDP, inflation, forex, fiscal deficit, current account deficit, interest rate cycle, economic recovery, RBI circulars, indirect taxes, GST, Insolvency and Bankruptcy imports, exports and everything that impacts Indian economy. 6. Geopolitics: Well-rounded and deeply researched coverage on US News, Oval Office European Union, Ukraine Russia War, middle-east crisis, royal families and global leaders like - Donald Trump, Vladimir Putin, Kim Jong Un, Xi Jinping and premiers of other leading economies in the world. Meet the Team 1. Gulam Jeelani, Political Affairs Editor 2. Sugam Singhal, Senior Assistant Editor 3. Chanchal, Assistant Editor 4. Sanchari Ghosh, Chief Content Producer 5. Pratik Prashant Mukane, Chief Content Producer 6. Sayantani Biswas, Chief Content Producer 7. Ravi Hari, Deputy Chief Content Producer 8. Garvit Bhirani, Deputy Chief Content Producer 9. Akriti Anand, Senior Content Producer 10. Jocelyn Felix Fernandes, Senior Content Producer 11. Swastika Das Sharma, Content Producer 12. Mausam Jha, Content Producer 13. Riya R Alex, Trainee Content Producer